Key facts
- It has raised $1.4M; the latest was Early Stage VC ($1.4M) in Feb 2025.
- Notable investors include Beautiful Mind Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zhongke Boxin Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhongke Boxin Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhongke Boxin Biotech
Developer of functional microecological agents for agriculture. the company has developed biologics that can improve the ecological balance in agriculture, general health, and pets by screening and optimizing high-quality strains, enabling users to solve problems such as antibiotic abuse and ecological imbalance.
- Sector
- Materials and Resources
- HQ
- Beijing, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Zhongke Boxin Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhongke Boxin Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhongke Boxin Biotech in its N-PORT filings yet. We sweep new filings monthly.